Scarica l'app Stockscreener
850.95
3.07%
-26.99
Dopo l'orario di chiusura:
844.00
-6.95
-0.82%
Argen X Se Adr Borsa (ARGX) Ultime notizie
Jefferies maintains Buy rating on argenx stock despite failed TED trial - Investing.com
Argenx stock rating maintained at Buy by BofA despite TED trial failure - Investing.com India
argenx stock rating reiterated at Buy by Guggenheim despite TED study halt - Investing.com
Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit - Benzinga
Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
argenx stock tumbles after discontinuing thyroid eye disease studies - Investing.com
Stifel raises argenx stock price target to $1,248 on Vyvgart dominance By Investing.com - Investing.com South Africa
Stifel raises argenx stock price target to $1,248 on Vyvgart dominance - Investing.com India
Argenx price target raised to $910 from $800 at UBS on Vyvgart growth By Investing.com - Investing.com South Africa
Argenx price target raised to $910 from $800 at UBS on Vyvgart growth - Investing.com India
DoorDash Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Argenx NV ADR stock hits all-time high at $934.62 - Investing.com India
Argenx NV ADR stock hits all-time high at $934.62 By Investing.com - Investing.com South Africa
If You Invested $1000 In argenx Stock 5 Years Ago, You Would Have This Much Today - Sahm
Looking Into argenx SE's Recent Short Interest - Sahm
ClearBridge International Growth ADR ESG Portfolios Q3 2025 Commentary - Seeking Alpha
This Argenx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Oppenheimer raises argenx stock price target to $1,040 on higher Vyvgart sales By Investing.com - Investing.com South Africa
Oppenheimer raises argenx stock price target to $1,040 on higher Vyvgart sales - Investing.com India
Quant Ratings Updated on 141 Stocks - InvestorPlace
Eli Lilly Upgraded, Chewy Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today - Sahm
Argenx stock reaches all-time high at 915.55 USD By Investing.com - Investing.com Nigeria
Argenx stock reaches all-time high at 915.55 USD - Investing.com
Stocks Showing Improving Market Leadership: argenx ADR Earns 84 RS Rating - MSN
Argenx NV ADR stock hits all-time high of 855.68 USD - Investing.com Nigeria
Argenx NV ADR stock hits all-time high of 855.68 USD By Investing.com - Investing.com South Africa
Janus Henderson Global Life Sciences Fund Q3 2025 Commentary - Seeking Alpha
argenx Announces VYVGART SC Prefilled Syringe for Self-Injection in Chronic Inflammatory Demyelinating Polyneuropathy Authorized for Sale by Health Canada - Barchart.com
Halozyme Beats on Q3 Earnings & Revenues, Raises 2025 View - Finviz
Piper Sandler raises argenx stock price target to $930 on strong Vyvgart sales By Investing.com - Investing.com South Africa
Piper Sandler raises argenx stock price target to $930 on strong Vyvgart sales - Investing.com
Vyvgart Fuels Strong Growth for Argenx and Supports Developing Pipeline - Morningstar
argenx SE stock price target raised to $1,146 from $800 at TD Cowen By Investing.com - Investing.com South Africa
argenx SE stock price target raised to $1,146 from $800 at TD Cowen - Investing.com India
argenx ADR earnings beat by $0.74, revenue topped estimates - Investing.com Canada
1.52%
1.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):